← back to search

Β. Michael Ghadimi

Universitätsmedizin Göttingen · DE
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, and Pancreatic and Hepatic Oncology Research.
h-index
40
citations
6,262
works
167
NIH funding
primary concept
email

Recent publications

CONKO-005: Adjuvant therapy in R0 resected pancreatic cancer patients with gemcitabine plus erlotinib versus gemcitabine for 24 weeks—A prospective randomized phase III study.
Journal of Clinical Oncology 2015cited by 26position: middledoi
Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of <i>SPP1</i> as an independent prognostic factor
International Journal of Cancer 2014cited by 23position: middledoi
Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer
Clinical Cancer Research 2013cited by 380position: middledoi
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
PLoS ONE 2012cited by 277position: middledoi
PAM4 enzyme immunoassay alone and in combination with CA 19‐9 for the detection of pancreatic adenocarcinoma
Cancer 2012cited by 46position: middledoi
Abstract 5005: Large-scale DNA methylation profiling in gastrointestinal stromal tumors (GIST) reveals epigenetic regulation of SPP1 as an independent prognostic factor
Cancer Research 2012cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jochen Gaedcke · Tver State Medical University3 papers (2012–2013)Aleksandra Balwierz · Princess Máxima Center2 papers (2012–2014)Aoife Ward · German Cancer Research Center2 papers (2012–2014)Florian Haller · University Hospital Heidelberg2 papers (2012–2014)Özgür Şahin · Medical University of South Carolina2 papers (2012–2014)Stefan Wiemann · German Cancer Research Center2 papers (2012–2014)Nader Hanna · Thomas Jefferson University2 papers (2012–2013)Jörg D. Hoheisel · German Cancer Research Center2 papers (2012–2014)Abbas Agaimy · Harvard University2 papers (2012–2014)Thomas Ried · National Cancer Institute2 papers (2012–2013)Jitao David Zhang · Roche (Switzerland)2 papers (2012–2014)Harris G. Yfantis · VA Maryland Health Care System2 papers (2012–2013)Yasser Riazalhosseini · National Institute of Pathology2 papers (2012–2014) · 2 papers (2012–2014)S. Perwez Hussain · National Institutes of Health2 papers (2012–2013)Inga‐Marie Schaefer · Harvard University2 papers (2012–2014)Geng Zhang · Hebei Medical University2 papers (2012–2013)Peijun He · University of Southampton2 papers (2012–2013)H. Richard Alexander · Rutgers, The State University of New Jersey2 papers (2012–2013)Ralph H. Hruban · Occupational Cancer Research Centre1 papers (2012–2012)